Bannerbild German Brest Group - Über uns

Partners with whom the GBG collaborates

Cooperation with clinical investigators, supervisory bodies, study groups and pharmaceutical manufacturers is of vital importance for the success of our clinical trials.

Networking – the key to research success

With around 500 study centres and more than 1,000 clinical investigators in Germany, the German Breast Group is a strong breast cancer research network. We also collaborate with numerous other national and international study groups and leading pharmaceutical manufacturers.

In order to promote the exchange of information between the clinical project managers, the trial managers and representatives from the pharmaceutical industry on a sustainable basis, we hold regular meetings at the study centres.

Continual monitoring of trial data

An independent Data and Safety Monitoring Committee (IDMC) ensures that trial data are monitored and that trials are conducted in compliance with good clinical practice (GCP). Twice a year, we provide the independent members of the IDMC with access to our current database for this purpose.

Global partnerships for new treatment methods

Nowadays, the development of new treatment methods for breast cancer calls for a high level of international cooperation involving scientists and practising physicians all over the world.

The implementation of international multicentric trials requires close cooperation with other national and international study groups. The German Breast Group is an important part of this global scientific network of clinical researchers. Prof. von Minckwitz is a member of the board of directors of the Breast International Group (BIG), an umbrella organisation with over 50 international breast cancer study groups. The BIG implements large-scale drug registration trials in cooperation with leading study groups and pharmaceutical manufacturers. The GBG has made a successful contribution to this work in the past and now manages trials itself on behalf of the umbrella association.

Our cooperation partners include the following organisations:

  • ABCSG: Austrian Breast & Colorectal Cancer Study Group
  • AGO: Arbeitsgemeinschaft Gynäkologische Onkologie 
  • AGO-B: Breast Study Group
  • BIG: Breast International Group
  • BOOG: Borstkanker Onderzoek Groep Nederland
  • BCIRG: Breast Cancer International Research Group
  • CECOG: Central European Cooperative Oncology Group
  • CRUK: Cancer Research UK
  • CTRU: Clinical Trials Research Unit
  • DBCG: Danish Breast Cancer Cooperative Group
  • DKG: Deutsche Krebsgesellschaft
  • GEICAM: Grupo Español de Investigación en Cáncer de Mama
  • IBCSG: International Breast Cancer Study Group
  • ICCG: International Collaborative Cancer Group
  • NOGGO: Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie
  • SBG: Scandinavian Breast Group
  • SOLTI: Grupo Espanol de Estudio Tratamiento y otras Estrategias Experimentales en Tumores Solidos
  • UZL: University Hospitals of Leuven

GBG Forschungs GmbH is also a member of the TMF (Technology and Methodology Platform for Networked Medical Research – Technologie- und Methodenplattform für die vernetzte medizinische Forschung e.V.).


Our Partners

Logo ABCSG
Logo DKG
Logo SOLTI
Logo AGO-B
Logo Geicam
Logo BIG
Logo IBCSG
Logo CECOG
Logo NOGGO
Logo Mitglied TMF

GBG Forschungs GmbH
Martin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440

+49 6102 7480-0 | nfGBGd